Vetter gains approval for new production plant
German company Vetter Pharma-Fertigung, which specializes in aseptic filling of liquid and lyophilised drugs, has received a manufacturing licence in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant Ravensburg Vetter South.
German company Vetter Pharma-Fertigung, which specializes in aseptic filling of liquid and lyophilised drugs, has received a manufacturing licence in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant Ravensburg Vetter South.
The plant, which took three years to plan and build and represents an investment of e100m, is said to be one of the world's most modern production facilities. It features a high level of automation and an ultra-modern Restricted Access Barrier System (RABS). In addition to dual-chamber syringes and cartridges, the new location will enable Vetter also to fill liquid or lyophilised vials, as well as single-chamber cartridges.
The new production lines are extremely flexible, making it possible to change systems and formats, including line clearance, cleaning and disinfection, much more quickly than with previous design concepts. With the new facility, Vetter is broadening its portfolio of services and expanding its capacity in aseptic manufacturing by around 30%.
